Birmingham, West Midlands -- (SBWIRE) -- 01/28/2014 -- Value Penny Stocks issues special report on Athersys, Inc. (NASDAQ:ATHX), ThermoGenesis Corp (NASDAQ:KOOL), Orexigen Therapeutics, Inc. (NASDAQ:OREX), Integrated Device Technology Inc (NASDAQ:IDTI).
Athersys, Inc. (NASDAQ:ATHX) ended its recent business day with the loss of -6.90% and closed at the price of $3.78 after opening at $4.09. The stock traded during its last trading session with the total volume of 4,428,627 shares, as compared to its average volume of 2.29 million shares. Athersys, Inc, a biotechnology company, focuses on the research and development in the field of regenerative medicine. The company’s lead platform product, MultiStem, an allogeneic stem cell product, which was evaluated in two completed Phase I clinical trials and is under two ongoing Phase II clinical trials for treating a range of diseases and various application in the field of clinical regenerative medicine.
Has ATHX Found The Bottom and Ready To Move Up? Find Out Here
ThermoGenesis Corp (NASDAQ:KOOL) remained among the day decliners and traded with volume of 4,405,712 shares in the last session, as compared to average volume of 2.10 million shares. In comparison with 52 week range of $0.71 - $3.24, it faced lowest price of $2.31 during the last trading session whereas its day highest price was $2.80. The company’s total market capitalization is $40.86 million, along with 16.68 million shares outstanding. ThermoGenesis Corp. designs, develops, and commercializes devices and disposable tools for the processing, storage, and administration of cell therapies. The company provides automated and semi-automated devices, and single-use processing disposables that enable hospitals and blood banks to manufacture a therapeutic dose of stem cells.
Has KOOL Found The Bottom And Ready To Gain Momentum? Find Out Here
Orexigen Therapeutics, Inc. (NASDAQ:OREX) showed 4,384,355 shares in volume during the last trading session, while the average trading volume remained 2.55 million shares. The stock kicked off its trading session at $6.78 and closed at $6.67 after declining -1.62%. Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its product candidates include Contrave, which has completed Phase III clinical trials and is being studied in a cardiovascular outcomes trial; and Empatic, which has completed Phase II clinical trials.
Why Should Investors Buy OREX After the Recent Fall? Just Go Here and Find Out
Integrated Device Technology Inc (NASDAQ:IDTI) stock traded during its last trading session with the total traded volume of 4,017,775 shares versus its average volume of 1.92 million shares. The company opened its trade at the price of $9.99 and its closing price was $9.66 after losing -7.74% for the day. Integrated Device Technology, Inc. designs, develops, manufactures, and markets a range of mixed signal semiconductor solutions for the communications, computing, and consumer industries worldwide. It operates in two segments, Communications, and Computing and Consumer.
Will IDTI Get Buyers Even After The Recent Rally? Find Out Here
About Value Penny Stocks:
Value Penny Stocks was made by Two Active traders, Steve and Wilson, whom have made a platform for traders in order to provide traders the #1 Penny Stock Newsletter which actually gives value to your money and makes your portfolio full of profits. We concentrate on small cap stocks that trade on NYSE, NASD, AMEX, OTCBB, and OTC exchanges. These are usually stocks that will trade under $5 a share and offer the utmost potential profit on your short or long term investment. We also devote ourselves to understanding the overall market situations and use this knowledge in order to gain a better perception during our stock picking decisions.
We at ValuePennyStocks.com are engaged in the business of marketing and advertising companies. All content on our website is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities.
Please Read Our Full Disclaimer at: http://www.valuepennystocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)